Welcome to CDC Stacks | The LLNA: A Brief Review of Recent Advances and Limitations - 4026 | CDC Public Access
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
The LLNA: A Brief Review of Recent Advances and Limitations
  • Published Date:
    Jun 16 2011
  • Source:
    J Allergy (Cairo). 2011; 2011.
Filetype[PDF - 564.65 KB]


Details:
  • Description:
    Allergic contact dermatitis is the second most commonly reported occupational illness, accounting for 10% to 15% of all occupational diseases. This highlights the importance of developing rapid and sensitive methods for hazard identification of chemical sensitizers. The murine local lymph node assay (LLNA) was developed and validated for the identification of low molecular weight sensitizing chemicals. It provides several benefits over other tests for sensitization because it provides a quantitative endpoint, dose-responsive data, and allows for prediction of potency. However, there are also several concerns with this assay including: levels of false positive responses, variability due to vehicle, and predictivity. This report serves as a concise review which briefly summarizes the progress, advances and limitations of the assay over the last decade.

  • Document Type:
  • Collection(s):
No Related Documents.
You May Also Like: